Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
- Year invested 2021
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Associated Team
- Company Status Private